Leadership & Governance

Key Ownership/Investors

The major ownership position and day-to-day operations of Arkion® Life Sciences are controlled by the committee of managers: Earnest W. Porta, President and CEO; Rick L. Stejskal, VP and CFO; Thomas A. Jerrell, VP-Research and Development; and Harvey L. (Lanny) Weaver, VP-Market Development. Minority ownership is held by the following: MCP Investment Company, LLC (Archer-Daniels Midland) and Rhonda Mendoza.

In October of 2002, Arkion® sold 60% of its interest in a subsidiary, Legacy for Life LLC of Melbourne, Florida, and then sold an additional 20% interest in July of 2007. Arkion® retains 20% interest in Legacy for Life, LLC, and Legacy is Arkion®'s exclusive distributor for certain products in the Dietary Health Supplement market.

Key Management/Personnel:

Operating Committee of Arkion® Life Sciences:

President/CEO, Arkion® Life Sciences — Earnest W. Porta

In July 2001, Mr. Porta became CEO of Arkion® Life Sciences. He held a similar position with DCV Inc.,from 1997 through 2001. From 1992 through 1997, he was President and Managing Director of DCV, Inc. Mr. Porta spent 17 years with DuPont in various operational capacities including management positions in research and development, marketing, and general management. From 1987 to 1992 he managed the DuPont methanol derivatives business and formed a number of joint ventures between DuPont and other companies. He received a B.S. in Chemical Engineering from Drexel Institute of Technology in 1965 and a Ph.D. in Chemical Engineering from Clarkson College of Technology in 1972.

Chief Financial Officer, Arkion® Life Sciences — Rick L. Stejskal

Mr. Stejskal has been with Arkion® Life Sciences as the CFO since its founding in 2001. Prior to that he held a similar position as Vice President of Financial Operations with DCV for nine years. From 1990 through 1992 he was Vice President-Controller of DuCoa a DuPont ConAgra joint venture with annual sales in excess of $100 million. From 1984 through 1990, Mr. Stejskal served in a number of audit, finance and accounting positions for ConAgra Inc. During the four years prior to that he worked as an internal auditor for the George A. Hormel Company. He holds a B.S. in Agricultural Economics and Business Administration from Kansas State University.

President, Bio-Technical Resources* and
Vice President of Research and Development, Arkion® Life Sciences — Thomas A. Jerrell

Mr. Jerrell has been with Arkion® and DCV since 1995 as its Director of Research and then V.P. of Research and Development. From 1990-1995 he was employed by DuPont but on loan to DCV, holding positions during that time as an engineering manager, a biochemical project manager and the person responsible for leading the Company's efforts in the Chitin and Chitosan areas. From 1973-1990, he worked at DuPont in a number of engineering and operations management positions. Mr. Jerrell received a B.S. in Chemical Engineering from the University of Illinois in 1973 and a M.S.I.A. degree from Purdue University.

Vice President of Market Development, Arkion® Life Sciences — Harvey L. (Lanny) Weaver

In July 2001, Mr. Weaver became Vice President of Arkion® Life Sciences. He held a similar position with DCV Inc. from 1997 through 2001. From 1990 through 1997, he was President of Weaver Associates, a management consulting business specializing in strategic business planning and marketing to the packaging industry. Mr. Weaver spent the previous 29 years with E.I. DuPont De Nemours and Co. He retired from the position of Business Director of Packaging Resins and Films with worldwide responsibility for Sales, Manufacturing, and R&D of that $750 million group. He received his B.S. in Cereal Chemistry from Florida State University.

Other Key Personnel:

President of Airepel® Structure Business — Chris Widrig

Mr. Widrig who joined Arkion® in 2003 is President of the Airepel Structure Business.  He has 25+ years of industrial experience. Prior to joining Arkion®, he spent the previous seven years in executive management positions with a DuPont joint venture, Royal-Dutch Shell (E&P), and Rhodia Eco Services where he had full P&L responsibility for a $200 million enterprise. He started his career with DuPont and held increasingly more responsible positions with the firm. He holds a Bachelor's Degree in Chemical Engineering and an MBA.

Vice President-AQ Crop Business — Ken Ballinger

Mr. Ballinger is responsible for managing Arkion®'s Agricultural Crop Business. He has been with Arkion® Life Sciences, since 1993 and has been responsible for developing the various uses for anthraquinone. Mr. Ballinger holds patents on FlightControl® PLUS and other uses of anthraquinone. He graduated from Bowdoin College with a Bachelor's Degree in Biology. He received his MBA from Long Island University in Marketing. His business experience has been with Johnson & Johnson and DuPont in Health Care Sales and Marketing Management and Business Development.

Vice President of Marketing, Animal Nutrition Products, Arkion® Life Sciences — Sam Walker

Mr. Walker is the Vice President of Marketing Animal Nutrition Products, including Protimax® and other animal feed products. He holds a Bachelors of Science degree from the University of Illinois in Animal Science and Business. He has over 30 years experience in the animal feed and animal health industries, mostly with Pfizer Animal Health Group. Sam has held a variety of positions in sales, marketing and management and has been involved in the launch of over 20 new products and product uses. He has extensive experience in the United States and international animal health markets.

Director of Quality and Technical Development, Arkion® Life Sciences — Les Confer

Mr. Confer offers over thirty years of experience in immunological-based biotechnology, including fifteen years of specific experience in hyperimmune antibody technology. He currently directs the Biologics Technical Development and Quality Unit for Arkion® Life Sciences, LLC. He held progressively responsible positions with several startup biotechnology ventures prior to joining DCV in 1996 and has been with Arkion® since its founding in 2001. Mr. Confer has played a key role in developing novel nutraceuticals, functional foods and nutritional supplements based on antibodies and immune co-factors derived from the eggs of hyperimmunized laying hens and subsequently ensuring product quality.

 

    *Bio-Technical Resources is Arkion®'s Biotechnology Business.